| Financial Year |
March 31 2023 |
| Monetary Funds |
554,452,276.73 |
| Held-for-trading Financial Assets |
6,803,350.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
441,444,070.10 |
| Advances to Suppliers |
50,303,551.25 |
| Other Receivables |
5,219,482.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,878,525,423.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,910,573.42 |
| Total Current Assets |
3,055,507,558.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,401,386.74 |
| Investment Properties |
-- |
| Fixed Assetes |
2,352,064,985.91 |
| Under-construction Projects |
424,253,690.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
368,342,503.88 |
| R&D expenses |
54,276,415.20 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,261,222.59 |
| Deferred Income Tax Assets |
7,740,830.69 |
| Other Non-Current Assets |
42,892,628.00 |
| Sub-Total of Non-Current Assets |
3,373,165,881.10 |
| Total Assets |
6,428,673,439.40 |
| Short-Term Loans |
1,383,517,039.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
622,197,468.44 |
| Accounts Payable |
383,930,816.78 |
| Accounts Received In Advance |
69,631.08 |
| Employee Compensation Payable |
74,877,653.76 |
| Taxes Payable |
28,073,203.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,766,413.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,249,054.93 |
| Other Current Liabilities |
544,307.61 |
| Sub-Total of Current Liabilities |
2,584,861,064.27 |
| Long-term Loans |
143,919,312.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,995,876.88 |
| Deferred Income Tax Liabilities |
8,437,433.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
244,106,260.90 |
| Total Liabilities |
2,828,967,325.17 |
| Paid-In Capital(Or Share Stock) |
347,977,159.00 |
| Capital Surplus |
1,494,723,765.70 |
| Surplus Reserve |
108,221,501.18 |
| LESS:Treasury Stock |
58,000,445.43 |
| Undistributed Profits |
1,706,921,233.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,599,706,114.23 |
| Owner's Equity（Stockholder's Equity） |
3,599,706,114.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,428,673,439.40 |
